Eco Animal Health Group Plc

• 

  29/11/11

  Canada and US could provide over third of ECO Animal Health’s future market, says Cenkos

  Canada and the United States can provide over a third of the potential world market for ECO Animal Health’s products, according to analysts at City broker Cenkos.

   

• 

  22/07/11

  ECO Animal Health Group’s shares higher after it delivers upbeat results

  Very strong progress in China, India and Japan helped ECO Animal Health to increase overall sales by more than a quarter last year. Meanwhile, the firm said its current year has started well too. House broker Cenkos believes the shares could be worth 600 pence each

• 

  03/02/11

  ECO Animal Health: growing fast while awaiting US launch

  The livestock therapeutic specialist is continuing organic growth in China, Latin America and India.  In the shorter term, investors will want to look out for news of US regulatory approval for its flagship product Aivlosin this year as well as full-year results that are expected to show a substantial increase in both turnover and profits. Longer term, a trade sale may be on the cards, chairman Peter Lawrence tells Proactive Investors.

• 

  11/03/10

  Eco Animal Health Group: moves into US and China could be transformational

  Aivlosin® now accounts for more than half of global sales for ECO. Sales in China during FY 2009 were more than 60% ahead of the previous year, and expectations for FY 2010 indicate similar progress.

• 

  23/09/09

  Eco Animal Health: helping the meat industry to stay in good shape

  The group’s flagship product is Aivlosin, which helps control diseases in pigs and chickens, but has potential for use in a wider range of animals

Connect with Facebook to view or add comments for this company